Tuesday, November 17, 2026

Ubie and Pfizer begin collaboration to provide medical consultation support for overactive bladder (OAB) patients

Ubie and Pfizer launched a collaboration between Ubie's web-based medical information service "Ubie AI Consultation" and Pfizer's disease awareness website "UUI Consultation Room" in October to help people suffering from overactive bladder (OAB) symptoms, including urge urinary incontinence, to seek medical attention at an early stage. The collaboration began in October. This collaboration is an initiative born out of Pfizer's open innovation "Pfizer Healthcare Hub Japan" (*1) with startup companies.

Disease context: OAB symptoms difficult to discuss, low consultation rate among women

Overactive bladder (OAB) is a symptom syndrome in which urgency to urinate is an essential symptom. Urgency urinary incontinence (UUI) is another symptom of OAB, and refers to a sudden, uncontrollable urge to urinate that causes a person to leak urine without making it to the bathroom in time.

Applying the results of an epidemiological survey published by the Japan Urinary Function Society in 2003 (*2) to the population composition in 2012, it is estimated that 10.4 million men and women aged 40 and over have OAB. Of these 10.4 million, 7.5 million are estimated to have UUI and 5.39 million to have UUI at least once a week.

On the other hand, the results of a survey (*3) in which patients were asked about the ease of consulting a physician regarding urinary symptoms indicated that urinary incontinence was the most difficult symptom for both men and women to consult. It was also reported that the rate of consultation with a medical institution was 22.7% (36.4% for men and 7.7% for women) among those with OAB symptoms (*2).
Thus, it is assumed that although there are more than 10 million patients with OAB, they are hesitant to consult a physician, which does not lead to early consultation with a medical institution.

Information provided by both companies: "Ubiquitous AI Medical Consultation" and "UUI Consultation Office".

Ubie provides "Ubie AI Consultation," a service that enables consumers to look up medical institutions that can provide consultation for their symptoms by answering questions from their smartphones or PCs. Pfizer also offers "UUI Consultation," a disease awareness website that is useful for people suffering from UUI and other OAB symptoms and their families.

Details of the collaboration: To lead to early consultation of patients in need with OAB.

The two companies will collaborate in providing information on OAB in order to solve the problems of patients who hesitate to visit medical institutions and are troubled by OAB. In this collaboration, when a visitor to the "Ubiquitous AI Consultation" answers that he/she is troubled with symptoms related to OAB, information on OAB and a link to Pfizer's "UUI Consultation Room" will be displayed, and the visitor can obtain substantial information related to OAB, including UUI, at the linked site.

The top page of the "UUI Consultation Room" displays a link to "Ubiquitous AI Consultation," which allows OAB sufferers to search for a nearby urologist or other medical institution after answering related symptoms.
Through the above collaboration, the two companies aim to enhance the provision of information to patients and contribute to patients suffering from UUI and other OAB symptoms.


*1: What is Pfizer Healthcare Hub Japan?
It is the Japanese version of the Pfizer Healthcare Hub, Pfizer's global open innovation initiative that collaborates with startup companies with digital health technologies and services to provide better solutions for patients.

Ubie spoke at pitch events held in November 2018 and August 2020. The two companies have been in discussions following this initiative, which led to this collaboration.

URL:https://www.pfizer.co.jp/pfizer/development/innovation/healthcarehub.html

2: Honma, Yukio et al.: Journal of the Japanese Society of Urinary Function 14(2): 266, 2003
3: Manabu Toyama, et al: Journal of the Japanese Society of Clinical Internal Medicine 24(1): 108, 2009

Ubiquitous AI Medical Consultation" for consumers

Ubiquitous Medical Consultation" is a Web-based medical information service that supports consumers in obtaining appropriate medical care. It allows users to look up the name of a related disease and the appropriate place to receive medical care anytime, anywhere from symptoms of concern. The service supports appropriate medical consultation behavior at local medical institutions such as family doctors, ambulance services such as #7119, and public telephone consultation services such as the Ministry of Health, Labor and Welfare. As of September 2021, more than 3 million people use the system monthly.

URL:https://ubie.app/

About UUI Consultation Office

The website provides OAB patients and their families with a wide range of information, including causes and countermeasures for UUI and other OAB symptoms, doctors' and patients' opinions about visiting medical institutions, the flow of examination and consultation, and useful information about leakage and frequent urination. It also contributes to patients suffering from UUI and other OAB symptoms by providing a "medical interview sheet" that enables patients to tell their doctors about symptoms they are reluctant to mention.

URL:https://www.oab-info.com/

About Ubie Corporation

A health tech startup founded in May 2017 by a doctor and an engineer with the mission of "guiding people to appropriate medical care with technology," it uses AI as its core technology to develop and provide "Ubiquitous AI consultation," which guides people from symptoms to appropriate medical care, and "Ubiquitous AI medical interview," which improves operational efficiency at medical facilities. Ubiquitous AI is a core AI technology that guides patients to appropriate medical care based on their symptoms. The company is working to create a society in which everyone has access to medical care that suits them best.

name of companyUbie Corporation
EstablishmentMay 2017
LocationFukushima Bldg. 6F, 1-5-3 Nihonbashi-Muromachi, Chuo-ku, Tokyo 103-0022, Japan
representativeCo-Chairman of the Board Yoshimichi Abe, M.D.
Tsuneta Kubo, Co-Chairman, Engineer
uniform resouce locatorhttps://ubie.life

About Pfizer Japan Inc.

Pfizer leverages science and global resources to provide treatments that help people live longer, healthier lives and significantly improve their lives. The company also sets the standard for quality, safety and value in the discovery, development and manufacture of healthcare products, including innovative medicines and vaccines. Every day, Pfizer employees contribute to the health of people around the world by providing better prevention and treatments for life- and life-threatening diseases. As one of the world's leading innovative pharmaceutical companies, it is our responsibility to work with healthcare professionals, governments, and communities around the world to ensure that everyone has easy access to reliable healthcare. To meet people's expectations, Pfizer has been moving forward for more than 70 years.

name of companyPfizer Japan Inc.
EstablishmentAugust 1953
LocationShinjuku Bunka Quint Building, 3-22-7 Yoyogi, Shibuya-ku, Tokyo 151-8589, Japan
representativeAkihisa Harada, President and Representative Director
uniform resouce locatorJapan Corporationwww.pfizer.co.jp
globalwww.pfizer.com
PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。